KNect365 Life Sciences recently (Aug 2018) conducted a survey of antibody therapeutics professionals from across pharma and biotech, academia, service providers, CDMOs and CROs around the world. The survey explored the latest trends in therapeutic discoveries, clinical trials, manufacturing, delivery, regulations and business acquisitions.
This report based on 174 responses reveals unique insights into how industry insiders view the state of the antibody therapeutics industry in 2018; the hottest potential opportunities; the biggest challenges and how they are tackling them.
To introduce the report, Dan Stanton, editor of BioProcess Insider, explores what some of the key takeaways mean for the industry.
To download the exclusive report simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
Have any questions about the report or interested in sponsoring a future report? Email andrew.burrows@informa.com.
Log in or Create an Informa Connect Account to Access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.